GOLDMAN SACHS GROUP INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 202 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$12,874,092
+19.4%
2,254,657
+4.8%
0.00%0.0%
Q1 2024$10,782,292
-41.5%
2,152,154
+5.1%
0.00%
-33.3%
Q4 2023$18,415,619
+61.0%
2,048,456
+39.1%
0.00%
+50.0%
Q3 2023$11,440,051
-32.2%
1,472,336
-15.6%
0.00%
-50.0%
Q2 2023$16,883,904
+55.7%
1,744,205
+76.3%
0.00%
+100.0%
Q1 2023$10,845,731
+433.4%
989,574
+110.2%
0.00%
Q4 2022$2,033,481
+56908.2%
470,713
-0.7%
0.00%
-100.0%
Q3 2022$3,567
-50.7%
474,240
-34.2%
0.00%
-50.0%
Q2 2022$7,241
-99.8%
720,434
+132.6%
0.00%
+100.0%
Q1 2022$3,834,000
-38.7%
309,707
+13.3%
0.00%0.0%
Q4 2021$6,253,000
+60.5%
273,422
+55.3%
0.00%0.0%
Q3 2021$3,895,000
+75.4%
176,045
+2.7%
0.00%
Q2 2021$2,221,000
-42.9%
171,371
-42.8%
0.00%
-100.0%
Q1 2021$3,891,000
+64.0%
299,702
+74.7%
0.00%0.0%
Q4 2020$2,373,000
-10.4%
171,568
-4.6%
0.00%0.0%
Q3 2020$2,648,000
-39.4%
179,775
-33.1%
0.00%0.0%
Q2 2020$4,368,000
-50.7%
268,846
-55.9%
0.00%
-66.7%
Q1 2020$8,855,000
-29.8%
610,282
-2.0%
0.00%0.0%
Q4 2019$12,618,000
+42.9%
622,804
-62.3%
0.00%0.0%
Q3 2019$8,831,000
+18.3%
1,653,702
+45.7%
0.00%
+50.0%
Q2 2019$7,468,000
-16.7%
1,135,028
-17.7%
0.00%
-33.3%
Q1 2019$8,965,000
-20.9%
1,379,301
-17.0%
0.00%
-25.0%
Q4 2018$11,340,000
-2.0%
1,662,772
-4.6%
0.00%
+33.3%
Q3 2018$11,576,000
+12.1%
1,743,340
-5.0%
0.00%0.0%
Q2 2018$10,327,000
+60.2%
1,834,325
+47.7%
0.00%
+50.0%
Q1 2018$6,446,000
+19.1%
1,241,995
+4.0%
0.00%
+100.0%
Q4 2017$5,411,000
-1.4%
1,194,550
+36.5%
0.00%0.0%
Q3 2017$5,486,000
+2.1%
874,911
-0.2%
0.00%0.0%
Q2 2017$5,373,000
+45.9%
876,461
+74.7%
0.00%0.0%
Q1 2017$3,682,000
+37.5%
501,645
-60.6%
0.00%0.0%
Q4 2016$2,677,000
+136.9%
1,274,696
+239.6%
0.00%
Q3 2016$1,130,000
+1752.5%
375,309
+1677.2%
0.00%
Q1 2016$61,00021,1180.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Abingworth LLP 400,434$2,655,0001.58%
NEA Management Company, LLC 4,808,483$31,928,0001.38%
Kazazian Asset Management, LLC 170,356$1,131,0001.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 212,865$1,413,0000.99%
Vivo Capital, LLC 1,213,290$8,056,0000.81%
Polar Capital LLP 2,811,516$18,668,0000.16%
Cutler Capital Management, LLC 55,000$254,0000.11%
Patriot Financial Group Insurance Agency, LLC 20,000$133,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 77,913$517,0000.05%
MGO ONE SEVEN LLC 11,000$73,0000.03%
View complete list of AURINIA PHARMACEUTICALS INC shareholders